EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Morphine and hydromorphone pharmacodynamics in human volunteers: population-based modelling of interindividual response variability and utility

Erik Olofsen, Konrad Meissner, Albert Dahan, Evan D Kharasch

British Journal of Anaesthesia · 2026

DOI: 10.1016/j.bja.2025.11.060 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Anaesthesia, 2026. Verfasst von Erik Olofsen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Hydromorphone, Morphine, Analgesics, Opioid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, Foundation for Barnes-Jewish Hospital, Institute of Clinical and Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Morphine and hydromorphone differ in onset, magnitude, and duration of effects, all which exhibit considerable interindividual variability, but do not differ in interindividual pharmacokinetic variability. This secondary analysis of a previous study modelled morphine and hydromorphone pharmacodynamics (concentration-effect relationships) to compare their pharmacodynamic variability. METHODS: In a balanced crossover, 51 healthy volunteers received a 2-h infusion of 0.05 mg kg-1 morphine or 0.2 mg kg-1 hydromorphone. Measurements included analgesic response to thermal stimulus (maximally tolerated temperature, verbal pain scores at specific temperatures), pupil diameter, respiratory rate, and end-expired CO2 concentration. Morphine and hydromorphone pharmacodynamic effects were analysed together in a single model, for each clinical endpoint, with drug as a covariate, to allow assessment of interindividual and drug differences. Pharmacodynamic parameters were centred at their average, whereas a factor determined the difference from average. Models were fitted in NONMEM. Utility functions were constructed using effect-site concentrations. RESULTS: Analysis focused on potency parameters, blood-effect-site equilibration half-lives (t½ke0) and interindividual variabilities. Limit temperature modelling afforded separate morphine (46.9 ng ml-1) and hydromorphone (4.4 ng ml-1) potencies, whereas t½ke0 was not significantly different between morphine (0.71 h) and hydromorphone (0.75 h), although it was generally slower for morphine for other outcomes. Interindividual variabilities (% coefficient of variation) in potency and t½ke0 for various clinical effects were large, and varied between different effect measures, but none of the interindividual variabilities were significantly different between opioids. CONCLUSIONS: There was considerable interindividual variability in pharmacodynamic effect parameters for both morphine and hydromorphone, but no major variability differences between the opioids. Pharmacodynamic potencies for the various endpoints were different between opioids, but of the same order of magnitude for each opioid. The utility function was more favourable for hydromorphone than for morphine. These results might influence patient- and procedure-specific opioid selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydromorphoneMorphineAnalgesics, OpioidHumansCross-Over StudiesMaleAdultFemaleYoung AdultModels, BiologicalPupilDose-Response Relationship, DrugPain MeasurementMiddle Aged

Stichwörter der Autor:innen

PKPD modellingclinical pharmacologyhydromorphonemorphinepharmacodynamicspharmacokineticspopulation modellingsecondary analysis

Substanzen

HydromorphoneMorphineAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Klinik für Anästhesiologie, Universitätsmedizin Göttingen, Göttingen, Germany.
  • MediD Consultancy Group, Amsterdam, The Netherlands; Centre for Human Drug Research, Leiden, The Netherlands; Outcomes Research Consortium, Houston, TX, USA.
  • Department of Anesthesiology, Duke University, Durham, NC, USA; Bermaride LLC, Durham, NC, USA. Electronic address: evan.kharasch@duke.edu.

Förderung

  • NIDA NIH HHS
  • Foundation for Barnes-Jewish Hospital
  • Institute of Clinical and Translational Sciences
  • National Institutes of Health

Zitieren

APA

Olofsen, E., Meissner, K., Dahan, A., & Kharasch, E. D. (2026). Morphine and hydromorphone pharmacodynamics in human volunteers: population-based modelling of interindividual response variability and utility. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2025.11.060

Vancouver

Olofsen E, Meissner K, Dahan A, Kharasch ED. Morphine and hydromorphone pharmacodynamics in human volunteers: population-based modelling of interindividual response variability and utility. British Journal of Anaesthesia. 2026. doi:10.1016/j.bja.2025.11.060

BibTeX
@article{Olofsen2026,
  author = {Olofsen, Erik and Meissner, Konrad and Dahan, Albert and Kharasch, Evan D},
  title = {Morphine and hydromorphone pharmacodynamics in human volunteers: population-based modelling of interindividual response variability and utility},
  journal = {British Journal of Anaesthesia},
  year = {2026},
  doi = {10.1016/j.bja.2025.11.060}
}
Kostenlos starten →